| P50 | author | Mohammad Ali Sahraian | Q6891775 |
| | Amir Reza Azimi | Q125316876 |
| | Nima Rezaei | Q26464741 |
| P2093 | author name string | Farnaz Najmi Varzaneh | |
| | Fatemeh Najmi Varzaneh | |
| P2860 | cites work | A novel endogenous erythropoietin mediated pathway prevents axonal degeneration | Q28579124 |
| | Axonal transection in the lesions of multiple sclerosis | Q29615585 |
| | Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis | Q30767765 |
| | Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole | Q33586037 |
| | Treatment of multiple sclerosis: recent trials and future perspectives | Q33739573 |
| | Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials | Q33912538 |
| | Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. | Q34132516 |
| | Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models | Q34325318 |
| | The mechanism of action of methylprednisolone in the treatment of multiple sclerosis | Q34559491 |
| | Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis. | Q35937975 |
| | Erythropoietin: novel approaches to neuroprotection in human brain disease | Q35956310 |
| | The brain erythropoietin system and its potential for therapeutic exploitation in brain disease | Q36455213 |
| | Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury | Q37250532 |
| | Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo | Q41559138 |
| | Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. | Q45086893 |
| | Erythropoietin treatment improves neurological functional recovery in EAE mice | Q45266659 |
| | Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis | Q48475566 |
| | Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study | Q48650224 |
| | Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions | Q48791086 |
| | Progressive cerebral atrophy in multiple sclerosis. A serial MRI study | Q48840100 |
| | Recombinant erythropoietin down-regulates IL-6 and CXCR4 genes in TNF-alpha-treated primary cultures of human microvascular endothelial cells: implications for multiple sclerosis | Q48957653 |
| | Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. | Q53913927 |
| | Beneficial effect of erythropoietin on experimental allergic encephalomyelitis. | Q54128490 |
| | Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 |
| | Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury | Q24530090 |
| | Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria | Q24605493 |
| | Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress | Q24611053 |
| P433 | issue | 4 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| | erythropoietin | Q218706 |
| | methylprednisolone | Q417222 |
| P304 | page(s) | 273-278 | |
| P577 | publication date | 2014-03-07 | |
| P1433 | published in | Acta Neurologica Belgica | Q15749693 |
| P1476 | title | Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis | |
| P478 | volume | 114 | |